• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

生命表分析中生存概率和分位数的近似置信区间。

Approximate confidence intervals for probabilities of survival and quantiles in life-table analysis.

作者信息

Anderson J R, Bernstein L, Pike M C

出版信息

Biometrics. 1982 Jun;38(2):407-16.

PMID:7115871
Abstract

For survival probabilities with censored data, Rothman (1978, Journal of Chronic Diseases 31, 557-560) has recommended the use of quadratic confidence limits based on the assumption that the product of the 'effective' sample size at time t and the life-table estimate of the survival probability past time t follows a binomial distribution. This paper shows that the proposed confidence limits are asymptotically correct for continuous survival data. These intervals, as well as those based on the arcsine transformation, the logit transformation and the log(--log) transformation, are compared by simulation to those based on Greenwood's formula--the usual method of interval estimation in life-table analysis. With large amounts of data, the alternatives to the Greenwood method all produce acceptable intervals. On the basis of overall performance, the intervals suggested by Rothman are preferred for smaller samples. Any of these methods may be used to generate confidence sets for the median survival time or for any other quantile.

摘要

对于含有删失数据的生存概率,罗斯曼(1978年,《慢性病杂志》第31卷,557 - 560页)建议使用基于以下假设的二次置信限:时间t处的“有效”样本量与时间t之后生存概率的生命表估计值之积服从二项分布。本文表明,对于连续生存数据,所提出的置信限在渐近意义上是正确的。通过模拟将这些区间以及基于反正弦变换、对数it变换和对数(-对数)变换的区间与基于格林伍德公式的区间进行比较——格林伍德公式是生命表分析中常用的区间估计方法。对于大量数据,格林伍德方法的替代方法都能产生可接受的区间。基于整体性能,对于较小样本,罗斯曼建议的区间更受青睐。这些方法中的任何一种都可用于生成中位生存时间或任何其他分位数的置信集。

相似文献

1
Approximate confidence intervals for probabilities of survival and quantiles in life-table analysis.生命表分析中生存概率和分位数的近似置信区间。
Biometrics. 1982 Jun;38(2):407-16.
2
[Five methods for the estimation of confidence intervals on survival rate].[估计生存率置信区间的五种方法]
Zhonghua Liu Xing Bing Xue Za Zhi. 1995 Oct;16(5):306-9.
3
A comparison of reflected versus test-based confidence intervals for the median survival time, based on censored data.基于删失数据的中位数生存时间的反射置信区间与基于检验的置信区间的比较。
Biometrics. 1984 Sep;40(3):587-600.
4
Bootstrap-type confidence intervals for quantiles of the survival distribution.生存分布分位数的自助法置信区间。
Stat Med. 2001 Jun 15;20(11):1693-702. doi: 10.1002/sim.709.
5
Accurate confidence limits for quantiles under random censoring.随机删失下分位数的精确置信限
Biometrics. 1997 Dec;53(4):1399-415.
6
Approximate simultaneous confidence intervals for multiple contrasts of binomial proportions.二项比例多重对比的近似同时置信区间。
Biom J. 2008 Oct;50(5):782-92. doi: 10.1002/bimj.200710465.
7
[The parasite capacity of the host population].[宿主群体的寄生虫感染能力]
Parazitologiia. 2002 Jan-Feb;36(1):48-59.
8
Modification of the Greenwood formula for correlated response times.用于相关反应时间的格林伍德公式修正
Biometrics. 1997 Sep;53(3):885-99.
9
Likelihood-based confidence intervals for a log-normal mean.基于似然法的对数正态均值置信区间。
Stat Med. 2003 Jun 15;22(11):1849-60. doi: 10.1002/sim.1381.
10
A note on confidence intervals for the restricted mean survival time based on transformations in small sample size.基于小样本量变换的受限平均生存时间置信区间的一则注释
Pharm Stat. 2022 Mar;21(2):309-316. doi: 10.1002/pst.2170. Epub 2021 Sep 21.

引用本文的文献

1
Inference for treatment-specific survival curves using machine learning.使用机器学习对特定治疗的生存曲线进行推断。
J Am Stat Assoc. 2024;119(546):1541-1553. doi: 10.1080/01621459.2023.2205060. Epub 2023 Jun 5.
2
An evaluation of confidence intervals for a cumulative proportion to enable decisions at interim reviews of single-arm trials.累积比例置信区间的评估,以便在单臂试验的中期审查时做出决策。
Contemp Clin Trials. 2024 Mar;138:107453. doi: 10.1016/j.cct.2024.107453. Epub 2024 Jan 20.
3
Informational feedback accelerates learning in multi-alternative perceptual judgements of orientation.
信息反馈加速多选择感知判断方向的学习。
Vision Res. 2023 Dec;213:108318. doi: 10.1016/j.visres.2023.108318. Epub 2023 Sep 22.
4
Surgical options of the breast and clinical outcomes of breast cancer patients after neoadjuvant chemotherapy: A single-center retrospective study.乳腺癌患者新辅助化疗后的乳房手术选择及临床结局:一项单中心回顾性研究。
Front Oncol. 2022 Oct 27;12:984587. doi: 10.3389/fonc.2022.984587. eCollection 2022.
5
Efficacy of cetuximab plus PD-1 inhibitor differs by HPV status in head and neck squamous cell carcinoma: a systematic review and meta-analysis.西妥昔单抗联合 PD-1 抑制剂对头颈部鳞状细胞癌疗效的 HPV 状态依赖性:系统评价和荟萃分析。
J Immunother Cancer. 2022 Oct;10(10). doi: 10.1136/jitc-2022-005158.
6
Trastuzumab plus docetaxel and capecitabine as a first-line treatment for HER2-positive advanced gastric or gastroesophageal junction cancer: a phase II, multicenter, open-label, single-arm study.曲妥珠单抗联合多西他赛和卡培他滨作为HER2阳性晚期胃癌或胃食管交界癌的一线治疗:一项II期、多中心、开放标签、单臂研究。
Am J Cancer Res. 2020 Sep 1;10(9):3037-3046. eCollection 2020.
7
Phase II study of trastuzumab with modified docetaxel, cisplatin, and 5 fluorouracil in metastatic HER2-positive gastric cancer.曲妥珠单抗联合改良多西他赛、顺铂和氟尿嘧啶治疗转移性 HER2 阳性胃癌的 II 期研究。
Gastric Cancer. 2019 Mar;22(2):355-362. doi: 10.1007/s10120-018-0861-7. Epub 2018 Aug 7.
8
Paclitaxel as third-line chemotherapy for small cell lung cancer failing both etoposide- and camptothecin-based chemotherapy.紫杉醇作为依托泊苷和喜树碱为基础的化疗均失败后的小细胞肺癌三线化疗药物。
Medicine (Baltimore). 2017 Oct;96(42):e8176. doi: 10.1097/MD.0000000000008176.
9
Phase III randomized study of rituximab/carmustine, etoposide, cytarabine, and melphalan (BEAM) compared with iodine-131 tositumomab/BEAM with autologous hematopoietic cell transplantation for relapsed diffuse large B-cell lymphoma: results from the BMT CTN 0401 trial.三期随机研究比较了利妥昔单抗/卡莫司汀、依托泊苷、阿糖胞苷和马法兰(BEAM)与碘-131 托西莫单抗/BEAM 联合自体造血细胞移植治疗复发弥漫性大 B 细胞淋巴瘤:来自 BMT CTN 0401 试验的结果。
J Clin Oncol. 2013 May 1;31(13):1662-8. doi: 10.1200/JCO.2012.45.9453. Epub 2013 Mar 11.
10
Gemcitabine-based versus fluoropyrimidine-based chemotherapy with or without platinum in unresectable biliary tract cancer: a retrospective study.吉西他滨与氟嘧啶为基础的化疗联合或不联合铂类用于不可切除胆管癌的疗效比较:一项回顾性研究
BMC Cancer. 2008 Dec 18;8:374. doi: 10.1186/1471-2407-8-374.